(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-aminopropanoic acid, 95.0%, 1g

TERT-BUTYL 4-(HYDRAZINECARBONYL)-4-METHYLPIPERIDINE-1-CARBOXYLATE, 90.0%, 250mg

2-(4-Hydroxy-3-methylphenyl)acetic acid methyl ester, 95.0%, 250mg

(S)-3-METHYLCYCLOHEXANONE, 95.0%, 250mg

Solución modificadora de matriz de nitrato de paladio, 2 g/L Pd(NO3)2 (99,999%) en HNO3 al 1%

SCLAREOL, 98%, 250mg

1,4-Dioxaspiro[4.5]decan-8-ylhydrazine dihydrochloride, 98%, 1g

(4-Oxo-piperidin-1-yl)-acetic acid hydrochloride, 97%, 5g

1-(2,4-Dimethyl-1,3-thiazol-5-yl)methanamine, 95.0%, 250mg

Furan-3,4-dicarboxylic acid, 95.0%, 100mg

2-Bromotetrafluoroethyl trifluorovinyl ether, 97.0%, 5g

Acetonitrilo D3, 99,8 at%D, 25 ml, envase de vidrio

2-Bromo-2-methylpropiophenone, 95.0%, 1g